Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023

Shagun Bindlish; Jennifer Ng; Wissam Ghusn; Angela Fitch; Harold Bays

doi:10.1016/j.obpill.2023.100092

October 19, 2023Obesity PillarsOpen Access

Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023

View Full Paper

Ask AI

Bookmark

Share

Key Points

Provide clinical practice guidance for clinicians managing thrombosis, venous disease, lymphatic disease, and lipedema in patients with obesity.
Clinical practice statement developed by the Obesity Medicine Association writing committee.
Outlines the pathophysiologic links and clinical management strategies between obesity, vascular disorders, and abnormal fat distribution conditions such as lipedema.
Provides clinical recommendations to assist healthcare practitioners in identifying and treating venous, lymphatic, and thrombotic complications in patients with obesity.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Clinical practice statement outlines management of thrombosis, venous disease, and lipedema in obesity, highlighting evidence-based clinical strategies.

Abstract

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) on obesity, thrombosis, and venous/lymphatic disease is one of a series of OMA CPSs designed to assist clinicians in the care of patients with the disease of obesity.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bindlish et al. (2023) studied this question.

synapsesocial.com/papers/69d7c46c7392c8ce61bed9df https://doi.org/10.1016/j.obpill.2023.100092

View Full Paper

Ask AI

Bookmark

Share

Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading